Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
Journal of Inflammation Research, 2013 Maurizio Cutolo, Marianna Meroni Research Laboratories and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy Abstract: Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected ...
Cutolo M, Meroni M
doaj
Characterization of Jak, STAT, and Src interactions in Head and Neck Squamous Cell Carcinoma [PDF]
, 2013 Recurrence of Head and Neck Squamous Cell Carcinoma (HNSCC) is common; thus, it is essential to improve the effectiveness and reduce toxicity of current treatments.
Jaseja, Reshma, Jaseja, Reshma
core
Novel Topical Treatments for Itch
Dermatology and TherapyThe experience of itch often poses a burden on patient quality of life and has the capacity to inflict significant suffering. Topical therapies are a mainstay of treatment for many cutaneous and systemic diseases and afford patients the opportunity to ...
Rami H. Mahmoud +3 more
doaj +1 more source
Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]
World J Gastrointest Pharmacol TherMalakar S, Giri S, Jena A, Nath P.
europepmc +1 more source
Janus kinase inhibitors in giant cell arteritis: unmet needs and new challenges. [PDF]
ReumatologiaGkouvi A +3 more
europepmc +1 more source
Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]
World J Gastrointest Pharmacol TherAhsan MU +5 more
europepmc +1 more source
Selective Janus kinase inhibitors exhibit different effects in murine immune aplastic anemia. [PDF]
HemasphereDurrani J +10 more
europepmc +1 more source
Three Janus kinase inhibitors in ulcerative colitis: is upadacitinib taking the lead? [PDF]
Intest ResJung YS.
europepmc +1 more source
The use of Janus kinase inhibitors to treat noninfectious uveitis. [PDF]
Eye (Lond)Beckman M +5 more
europepmc +1 more source